期刊文献+

广东省艾滋病感染者/患者的生存分析 被引量:18

Survival analysis of people living with HIV/AIDS in Guangdong Province
原文传递
导出
摘要 目的了解广东省是否需要治疗及治疗与否的艾滋病感染者/患者(HIV/AIDS)的生存时间,探讨影响HIV/AIDS生存时间的风险因素。方法采用回顾性队列研究。研究对象来自中国疾病预防控制信息系统/艾滋病综合防治信息系统/HIV/AIDS病例报告;纳入研究的对象为在2004年1月至2014年6月间报告的、现住址在广东省的、非港澳台及外籍的年龄在15岁以上的HIV/AIDS。采用乘积-极根法绘制4组生存曲线,用log-rank检验对多组生存曲线比较,多因素Cox比例风险模型对影响HIV/AIDS生存时间的风险因素进行分析。结果符合条件的HIV/AIDS病例共36 500例,最终纳入分析28 474例,男女性别比为3.54∶1,年龄以15-39岁为主(68.78%),婚姻状况以已婚为主(44.02%),传播途径以异性为主(55.33%),需要治疗的占71.68%,已治疗的有53.50%。8年生存率由高到低依次是不需治已治组(88.68%)、需治已治组(79.07%)、不需治未治组(70.14%)及需治未治组(42.92%)。4组生存曲线差异具有统计学意义(P〈0.01)。多因素Cox比例风险模型结果显示,男性的死亡风险是女性的1.42倍,15岁以上的病例每增加10岁死亡风险增加0.60倍,异性传播的死亡风险是同性传播的5.66倍,注射毒品传播的死亡风险是同性传播的9.60倍,首次检测CD4^+T细胞计数分组中,相对于〈200个/mm^3,200个/mm^3及以上各组的死亡风险由0.43倍逐渐降低到0.26倍。结论对HIV/AIDS病例进行治疗可以延长其生存时间,及早进行CD4+T细胞计数检测以明确病程,为是否开始艾滋病抗病毒治疗提供依据。 Objective To explore survival time and it's influencing factors among people with HIV / AIDS whether needing or having accepted highly active antiretroviral therapy( HAART) or not.Methods A retrospective cohort study was adopted. The subjects were obtained from Chinese national HIV / AIDS comprehensive control and prevention information system,presently living in Guangdong Province from January 2004 to June 2014,excluding less than 15 years old,Hong Kong,Macao,Taiwan,and foreign nationality. Survival curves of four groups were measured by productive-limit method. The difference of survival curves among all the groups were tested by log-rank. The risk factors affecting survival time of people with HIV / AIDS were analyzed by Cox proportional hazard model. Results A total of 28 474 cases were entered for analysis from 36 500 cases of HIV / AIDS who met the conditions. The sex ratio of male and female was 3. 54∶ 1. They were mainly at 15-39 years of age( 68. 78%). The marital status was mainly married( 44. 02%) and the route of transmission was mainly heterosexual( 55. 33%). Among them,71. 68% needed HAART and 53. 50% had accepted it. The eight-year survive rates from high to low were 88. 68%,79. 07%,70. 14%,and 42. 92% for the four groups of Not-need-but-treated,Needand-treated,Not-need-and-not-treated,and Need-but-not-treated,respectively( P〈0. 01). In the Cox proportional hazard model,the risk of death was 1. 42 times in males compared with females,increased0. 60 time for every 10 years of age in the cases aged above 15 years,5. 66 times in heterosexual transmission compared with homosexual transmission,and 9. 60 times in transmission by drug injection compared with homosexual transmission. Compared with the group of〈 200 counts / mm^3 in the initial test of CD4+T cells,the risk of death was decreased from 0. 43 gradually to 0. 26 time in the groups of ≥200 counts /mm^3. Conclusion HAART can extend the survival time of people living with HIV / AIDS. The test of CD4^+T cell counts should be conducted as soon as possible to confirm the course and provide the information for initiating HAART.
出处 《华南预防医学》 2015年第2期107-112,共6页 South China Journal of Preventive Medicine
关键词 HIV感染 获得性免疫缺陷综合征 CD4淋巴细胞计数 HIV infections Acquired immunodeficiency syndrome CD4 lymphocyte count
  • 相关文献

参考文献8

  • 1Nakagawa F, Lodwick RK, Smith C J, et al. Projected life expect- ancy of people with HIV according to timing of diagnosis [ J ]. AIDS,2012,26(3) :335 -343.
  • 2May M, Gompels M, Delpech V, et al. Impact of late diagnosis and treatment on life expectancy in people with HIV - 1 : UK collabo- rative HIV cohort (UK CHIC) study [J]. BMJ, 2011,343: d6016.
  • 3Aldaz P,Moreno-Iribas C, Egues N, et al. Mortality by causes in HIV-infected adults: comparison with the general population[ J ]. BMC Public Health,2011,11:300.
  • 4Zhang F, Dou Z, Ma Y, et al. Five-year outcomes of the China na- tional free antiretroviral treatment program [ J]. Ann Intern Med, 2009,15 (4) :241 -251.
  • 5张福杰,王健,王福生,等.国家免费艾滋病抗病毒药物治疗手册[M].3版.北京:人民卫生出版社,2012:183-185.
  • 6World Health Organization. Consolidated guideline on the use of antiretroviral drugs for treating and preventing HIV infection ( rec- ommendations for a public health approach ) [ R ]. Geneva: WHO, 2013.
  • 7Ingle SM, May MT, Gill M J, et al. Impact of risk factors for specif- ic causes of death in the first and subsequent years of antiretroviral therapy among HIV-infected patients [ J ]. Clin Infect DIS, 2014, 59(2) :287 -297.
  • 8Tate JP, Justice AC, Hughes MD, et al. An interuationally general- izable risk index for mortality after one year of antiretroviral thera- py [J]. AIDS,2013,27(4) :563 -572.

共引文献67

同被引文献165

  • 1张福杰,文毅,于兰,马烨,潘捷,赵燕.艾滋病的抗病毒治疗与我国的免费治疗现状[J].科技导报,2005,23(7):24-29. 被引量:106
  • 2王爱霞,王福生,王清玥,王健,冯铁建,卢洪洲,孙洪清,孙永涛,叶寒辉,李太生,李兴旺,刘正印,邢玉兰,何云,汪宁,吴昊,吴南屏,张福杰,周曾全,宫恩聪,赵红心,赵敏,唐小平,徐莲芝,徐小元,曹韵贞,康来仪,蒋岩,蔡卫平,樊庆泊,潘孝彰.艾滋病诊疗指南[J].中华传染病杂志,2006,24(2):133-144. 被引量:633
  • 3彭文伟.传染病学[M].北京:人民卫生出版社,1999..
  • 4栾承,刘民.影响AIDS患者生存时间的因素研究[J].中国艾滋病性病,2007,13(5):489-491. 被引量:24
  • 5Abaasa AM,Todd J,Ekoru K,et al. Good adherence to HAART and improved survival in a community HIV/AIDS treatment and care programme: the experience of the AIDS support organization (TASO) , Kampala, Uganda[ J]. BMC Health Services Research, 2008,8:241.
  • 6Cohen MS,Chen YQ, McCauley M, et al. Prevention of HIV - 1 infection with early antiretroviral therapy [ J ]. The New England Journal of Medicine,2011,365(6) : 493 -505.
  • 7Ewings FM, Bhaskaran K, Mclean K, et al. Survival following HIV infection of a cohort followed from seroconversion in the UK [J]. AIDS, 2008, 22(1) :89 -95.
  • 8Sieleunou I, Souleymanou M, Schonenberger AM, et al. Determi- nants of survival in AIDS patients on antiretroviral therapy in a ru- ral centre in the Tar-North Province, Cameroon [ J ]. Trop Med Int Health, 2009, 14( 1 ) :36 -43.
  • 9王盟,庞琳,吴尊友.影响HIV/AIDS人群死亡因素研究进展[J].中国艾滋病性病,2008,14(2):195-197. 被引量:23
  • 10陈惠丽,叶晓燕,李春娜.艾滋病患者抗病毒治疗前CD4^+水平与死亡率的关系[J].中国实用医药,2008,3(21):52-53. 被引量:10

引证文献18

二级引证文献164

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部